Objective: We investigated whether the addition of a luteal phase support drug benefits pregnancy and perinatal outcomes in modified natural-cycle frozen-thawed embryo transfer (mNC-FET) for women up ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback